Adolescence is a high-risk period during which youth with T1D often experience declines in illness management and increases in HbA1c. Black youth with T1D have higher HbA1cs and are more likely to engage in suboptimal management compared to White youth, elevating their risk. Parental monitoring, i.e., direct supervision of adolescents' daily diabetes care, is associated with youth diabetes management. eHealth interventions may be an effective strategy to increase parental monitoring with high dissemination potential. The present study explored caregivers’ and health care providers’ (HCP) impressions of The 3Ms, an eHealth intervention to improve parental monitoring of Black adolescents’ daily diabetes management. Semi-structured interviews were completed with caregivers (N=21) who completed The 3Ms and pediatric diabetes HCPs (N=7) . Data were analyzed using content analysis by two coders who resolved all coding discrepancies to consensus. Caregivers rated the helpfulness of The 3Ms 8.6 out of (SD = 1.4) and indicated a high likelihood of recommending The 3Ms to others (M = 9.2/10, SD = 1.4) . Primary themes were that The 3Ms was a helpful reminder to caregivers of the importance of parental supervision of adolescents’ diabetes care, The 3Ms mnemonic provided clear, simple supervision strategies, and the intervention increased collaboration between adolescents and caregivers. HCPs feedback centered on facilitators (e.g. HCP and institutional buy-in) and barriers (e.g. disruption to clinic flow, and resource limitations including space, staff, and technological resources) to using The 3Ms in diabetes clinics. HCPs reported that ancillary psychosocial support in conjunction with routine clinical care could benefit patients and families in improving diabetes health. Next steps include testing the efficacy of The 3Ms for improving caregivers’ supervision behaviors and improving youth diabetes outcomes.
M.Reardon: None. L.Mckenzie: None. A.I.Carcone: None. J.Weissberg-benchell: None. M.A.Evans: None. D.A.Ellis: None.
National Institute of Diabetes and Digestive and Kidney Diseases (DK11075- A1)